Mass. Neuroscience Co. Minerva Hit With Stock-Drop Suit
Massachusetts-based Minerva Neurosciences Inc. misled investors about the success of a clinical trial for its flagship drug candidate, causing stock prices to plummet when the drug's trial ultimately failed, according to...To view the full article, register now.
Already a subscriber? Click here to view full article